Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising ...
Moderna's early hantavirus vaccine research has boosted stock price, reflecting market interest. The vaccine is in initial ...
Shares of Moderna ( MRNA) were up nearly 7% in recent trading, following a 12% jump Friday, after Bloomberg reported the ...
Moderna stock climbed after the deadly hantavirus outbreak drew investors' attention to the company's ongoing infectious ...
Marjorie Taylor Greene and other conservative commentators have claimed that Moderna is developing a hantavirus mRNA vaccine.
RSV and flu mRNA vaccines struggle with lower durability, higher side effects, and weak uptake, leading to program cuts and ...
After a large trial showed stronger protection, regulators are weighing whether Moderna’s mRNA vaccine could become a U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results